Over 3 programmes, Professor Cliff Bailey and colleagues will assess the clinical evidence and opportunities offered by sodium-glucose co-transporter-2 (SGLT2) inhibitors in the management of type 2 diabetes and its cardio-renal complications.
The series will complete with 2 further update webinars later in the year, dates and times tbc.
 |
Programme 1 – Understanding SGLT2 inhibitionTuesday 9th February, 19.00Professor Cliff Bailey – Type 2 diabetes and SGLT2 inhibitors in context Click below to watch the webinar on-demand. Watch on-demand now Request a password This webinar is password protected, you will have received the password in the invitation email. If you don’t have a password please feel free to email us at: admin@issuesandanswers.org. |
 |
Programme 2 – SGLT2 inhibitors and the heartTuesday 23rd February, 19.00Professor Cliff Bailey – Effects of SGLT2 inhibitors on cardiovascular function Click below to watch the webinar on-demand. Watch on-demand now Request a password This webinar is password protected, you will have received the password in the invitation email. If you don’t have a password please feel free to email us at: admin@issuesandanswers.org. |
Don’t forget to share this programme with a colleague click here
This webinar is supported by Boehringer Ingelheim through an unrestricted educational grant
The content, opinions and statements made in this webinar are those of the presenters and do not necessarily reflect the views of the supporters, editors or editorial board and no liability is accepted for the consequences of any misleading or inaccurate information.
Your programme presenters
 |
Professor Cliff Bailey
Emeritus Professor of Clinical Science, Aston University, Birmingham |
 |
Professor Vinod Patel Professor, Diabetes and Clinical Skills, |
 |
Dr Martin Hadley-Brown
FRCGP, |
 |
Dr Pam Brown
GP, SA1 Medical Practice, |
